| Large variability of bathypelagic microbial eukaryotic communities across the world’s oceans MC Pernice, CR Giner, R Logares, J Perera-Bel, SG Acinas, CM Duarte, ... The ISME journal 10 (4), 945-958, 2016 | 170 | 2016 |
| Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer H Chereda, A Bleckmann, K Menck, J Perera-Bel, P Stegmaier, F Auer, ... Genome medicine 13, 1-16, 2021 | 77 | 2021 |
| PI3K: a master regulator of brain metastasis‐promoting macrophages/microglia R Blazquez, D Wlochowitz, A Wolff, S Seitz, A Wachter, J Perera‐Bel, ... Glia 66 (11), 2438-2455, 2018 | 72 | 2018 |
| Genomic predictors of good outcome, recurrence, or progression in high-grade t1 non–muscle-invasive bladder cancer J Bellmunt, J Kim, B Reardon, J Perera-Bel, A Orsola, A Rodriguez-Vida, ... Cancer Research 80 (20), 4476-4486, 2020 | 58 | 2020 |
| From somatic variants towards precision oncology: evidence-driven reporting of treatment options in molecular tumor boards J Perera-Bel, B Hutter, C Heining, A Bleckmann, M Fröhlich, S Fröhling, ... Genome medicine 10 (1), 1-15, 2018 | 52 | 2018 |
| Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection N Garcia-Giralt, J Du, J Marin-Corral, M Bódalo-Torruella, ... Scientific Reports 12 (1), 6929, 2022 | 21 | 2022 |
| Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis JJ de Jong, BP Valderrama, J Perera, N Juanpere, P Cejas, H Long, ... British Journal of Cancer 127 (2), 313-320, 2022 | 13 | 2022 |
| Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC P Rocha, D Ramal, E Ripoll, L Moliner, A Corbera, M Hardy-Werbin, ... JTO Clinical and Research Reports 2 (1), 100115, 2021 | 7 | 2021 |
| Clinical application of genomic high-throughput data: Infrastructural, ethical, legal and psychosocial aspects N Umbach, T Beißbarth, A Bleckmann, G Duttge, L Flatau, A König, ... European Neuropsychopharmacology 31, 1-15, 2020 | 6 | 2020 |
| Bioinformatic methods and resources for biomarker discovery, validation, development, and integration J Perera-Bel, A Leha, T Beissbarth Predictive Biomarkers in Oncology: Applications in Precision Medicine, 149-164, 2019 | 6 | 2019 |
| Using RNA-Seq Data for the Detection of a Panel of Clinically Relevant Mutations A Wolff, J Perera-Bel, HU Schildhaus, K Homayounfar, B Schatlo, ... German Medical Data Sciences: A Learning Healthcare System, 217-221, 2018 | 5 | 2018 |
| The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer LM Boll, J Perera-Bel, A Rodriguez-Vida, O Arpí, A Rovira, N Juanpere, ... Scientific Reports 13 (1), 15287, 2023 | 3 | 2023 |
| Dynamics of Gene Expression Profiling and Identification of High-Risk Patients for Severe COVID-19 A Rombauts, M Bódalo Torruella, G Abelenda-Alonso, J Perera-Bel, ... Biomedicines 11 (5), 1348, 2023 | 3 | 2023 |
| Identifying actionable variants in cancer-the dual web and batch processing tool MTB-Report NS Kurz, J Perera-Bel, C Höltermann, T Tucholski, J Yang, T Beissbarth, ... Stud. Health Technol. Inform. 296, 73-80, 2022 | 3 | 2022 |
| Pre-existing tumor host immunity characterization in resected non-small cell lung cancer P Rocha, M Rodrigo, L Moliner, S Menendez, L Masfarré, N Navarro, ... Lung Cancer 181, 107257, 2023 | 2 | 2023 |
| Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer L Segalés, N Juanpere, N Gallarín, M Lorenzo, D López, J Perera-Bel, ... Virchows Archiv, 1-10, 2023 | 1 | 2023 |
| Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort M E. Camarena, P Theunissen, M Ruiz Egozcue, J Ruiz-Orera, ... bioRxiv, 2023.10. 30.564375, 2023 | 1 | 2023 |
| An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response BT Baune, A Minelli, B Carpiniello, M Contu, J Domínguez Barragán, ... Frontiers in Psychiatry 14, 1279688, 2024 | | 2024 |
| NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer S Santana-Hernández, J Suarez-Olmos, S Servitja, P Berenguer-Molins, ... Journal of Experimental & Clinical Cancer Research 43 (1), 10, 2024 | | 2024 |
| Identifying long-term responders to immune checkpoint blockade: Potential utility of serum proteomic profiling in metastatic non-small cell lung cancer R Bach Mora, P Rocha, L Masfarre Pinto, N Navarro Gorro, A Rossell, ... ANNALS OF ONCOLOGY 34, 2023 | | 2023 |
